Atrial natriuretic peptide: Renal effects in cirrhosis of the liver

Seminars in Nephrology

Volumn 17, Issue 6, 1997, Pages 120-129

  Levy, Mortimer ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645883861     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kisch B: Electron microscopy of the atrium of the heart. Exp Med Surg 14:99-112, 1956
2. Jamison JD, Palade GE: Specific granules in atrial muscle. J Cell Biol 23:151-172, 1964
3. Debold AJ: Morphometric assessment of granulation in rat atrial cardiocytes. J Mol Cell Cardiol 10:717-724, 1978
4. Marie JP, Guillemot H, Halt PY: Le degre de granulation de cardiocytes auriculaires. Pathol Biol (Paris) 24:549-554, 1976
5. Okamoto H: An electron microscopic study of the specific granules in the atrial muscle cell upon administration of agents affecting autonomie nerves. Arch Histol Jpn 30:467-478, 1969
6. Debold AJ, Borenstein HB, Veress AT, et al: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94, 1981
7. Maack T, Camergo JF, Kleinen HD, et al: Atrial natriuretic factor: Structure and functional properties. Kidney Int 27:607-615, 1985
8. Debold A: A decade of atrial natriuretic factor research. Canada J Physiol Pharmacol 69:1480-1485, 1991
9. Goetz KL: Renal natriuretic peptide (urodilatin) and atriopeptin: Evolving concepts. Am J Physiol 261:F921-F932, 1991
10. Lewicki JA, Protter AA: Physiological studies of the natriuretic peptide family, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, NY, Raven 1995, pp 1029-1053
11. Veress AT, Chong CK, Field LJ, et al: Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high and low salt diets. Am J Physiol 269:R186-R192, 1995
12. Sonnenberg H, Honrath U, Chong CK: Proximal tubular function in transgenic mice overexpressing atrial natriuretic factor. Can J Physiol Pharmacol 72:1168-1170, 1994
13. Cernacek P, Maher E, Crawhall JC, et al: Renal dose response and pharmacokinetics of atrial natriuretic factor in dogs. Am J Physiol 255:R929-R935, 1988
14. Brenner BM, Ballerman BJ, Grundig ME, et al: Diverse biological actions of atrial natriuretic peptide. Physiological Rev 70:665-699, 1990
15. de Zeena D, Janssen WMJ, de Jong PE: Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 44:1115-1133, 1992
16. Levy M: Pathogenesis of sodium retention in early cirrhosis of the liver: Evidence for vascular overfilling. Semin Liver Dis 14:4-13, 1994
17. Levy M: Sodium retention and ascites formation in dogs with portal cirrhosis. Am J Physiol 233:(F)572-585, 1977
18. Levy M: Pathophysiology of ascites formation, in Epstein M (ed): The Kidney in Liver Disease. Philadelphia, PA, Hanley and Belfus Inc, 1996, pp 179-220
19. Epstein M: Atrial natriuretic factor and liver disease, in Epstein M (ed): The Kidney in Liver Disease. Philadelphia, PA, Hanley and Belfus, Inc, 1996, pp 339-358
20. Bernardo M, DiMarco C, Trevisani F, et al: Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 105:188-193, 1993
21. Bernardi M, Fomale L, DiMarco C, et al: Hyperdynamic circulation of advanced cirrhosis: A re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 22:309-318, 1995
22. Unikowsky B, Wexler MJ, Levy M: Dogs with experi-mental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest 72:1594-1604, 1983
23. Warner LC, Leung WM, Campbell P, et al: The role of resistance to atrial natriuretic peptide in the pathogenesis of sodium retention in hepatic cirrhosis, in Brenner BM, Laragh JH (eds): Progress in Atrial Peptide Research, vol. 3. Raven, New York, NY, 1989, pp 185-204
24. Maher E, Cernacek P, Levy M: Heterogeneous renal responses to atrial natriuretic factor. 1) Chronic caval dogs. Am J Physiol 257:(R)1057-1067, 1989
25. Maher E, Cernacek P, Levy M: Heterogeneous renal responses to atrial natriuretic factor. 2) Cirrhotic dogs. Am J Physiol 257(R): 1068-1074, 1989
26. Maher EA: Atrial natriuretic factor in two canine models of ascites: Cardiac release and heterogeneity of renal natriuretic response. Doctoral Thesis submitted to Department of Physiology, McGill University, Montreal, Canada, November 1988
27. Maher E, Cemacek P, Levy M: Physiological features of edematous dogs unresponsive to ANP. Am J Physiol 258(F):1490-1496, 1990
28. Legault L, Cernacek P, Levy M: Attempts to alter the heterogeneous response to ANP in sodium-retaining caval dogs. Can J Physiol Pharmacol 70:897-904, 1992
29. Legault L, Cernacek P, Levy M, et al: Renal tubular responsiveness to atrial natriuretic peptide in sodium retaining chronic caval dogs: A possible role for kinins and luminal actions of the peptide. J Clin Invest 90:1425-1435, 1992
30. Levy M, Cernacek P: Urinary sodium excretion in chronic caval dogs following combined infusion of mannitol and ANP. Am J Physiol 264(F):206-211, 1997
31. Abassi Z, Shuranyi E, Better OS, et al: Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome. J Am Soc Nephrol 2:1538-1544, 1992
32. Ni X, Cheng Y, Cao L, et al: Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile duct ligation. J Am Soc Nephrol 7:2110-2118, 1996
33. Levy M: Comparative effects of diuretics and atrial peptide in chronic caval dogs. Am J Physiol 258(F):768-774, 1990
34. Epstein M: Renal sodium handling in liver disease, in Epstein M (ed): The Kidney in Liver Disease. Philadelphia, PA, Hanley and Belfus Inc. 1996, pp 1-32
35. Salerno F, Badalamenti S, Incerti P, et al: Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology 8:21-26, 1988
36. Jepersen B, Eiskjaer H, Jensen JD, et al: Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. Scand J Clin Lab Invest 55:273-288, 1995
37. Komeichi H, Moreau R, Cailmail S, et al: Blunted natriuresis and abnormal systemic hemodynamic responses to c-type and brain natriuretic peptides in rats with cirrhosis. J Hepatol 22:319-325, 1995
38. Salo J, Jimenez W, Kuhn M, et al: Urinary excretion of urodilatin in patients with cirrhosis. Hepatology 24:1428-1432, 1996
39. Goldman R: Studies in diurnal variation of water and electrolyte excretion: Nocturnal diuresis of water and sodium in congestive cardiac failure and cirrhosis of the liver. J Clin Invest 30:1191-1199, 1951
40. Papper S, Rosenbaum JD: Abnormalities in the excretion of water and sodium in "compensated" cirrhosis of the liver. J Lab Clin Med 40:523-530, 1952
41. Calantonio D, Pasqualetti P, Casale R, et al: Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: Circadian Study. Life Sci 45:631-635, 1989
42. Panos MZ, Anderson JV, Payne N, et al: Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: Basal levels, changes during daily activity and nocturnal diuresis. Hepatology 16:82-87, 1992
43. Ruskoamo H: Atrial natriuretic peptide: Synthesis, release and metabolism. Pharmacol Rev 44:479-602, 1992
44. Morali G, Floras JS, Legault L, et al: Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites. Am J Med 91:383-392, 1991
45. Cernacek P, Levy M: Renal bradykinin deficiency in dogs retaining sodium after constriction of the thoracic inferior vena cava. Clin Invest Med 18:B94, 1995 (abstr)
46. Skorecki KL, Leung WM, Campbell P, et al: Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Am J Med 85:375-382, 1988